학술논문

Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial
Document Type
Article
Author
Burns, D.K.Chiang, C.Haneline, S.Saunders, A.M.Alexander, R.C.Culp, M.Evans, R.M.Wu, J.Schwarz, A.J.Ratti, E.Welsh-Bohmer, K.A.Plassman, B.L.Burke, J.R.Lutz, M.W.O'Neil, J.Harrigan, P.Schneider, L.S.Yaffe, K.Aarsland, D.Ackermann, O.Agron-Figueroa, J.Arnold, T.Bailey, P.Ballard, C.Barton, S.Belden, C.Bergthold, J.Bond, W.Bradley, R.Braude, W.Brody, M.Brown, R.Burke, J.Butchart, J.Campbell, T.Carusa, S.Clarnette, R.Cohen, R.Connelly, P.Copeland, J.Coulthard, E.Crusey, J.Curtis, C.De Sanctis, V.Demakis, G.Denburg, N.Donikyan, M.Doody, R.Ellenbogen, A.Fleischman, D.Floel, A.Forchetti, C.Galvez-Jimenez, N.Goldstein, J.Goldstein, F.Goozee, K.Gruener, D.Halsten, J.Hassman, H.Henderson, E.Herbst, H.-P.Higham, S.Hofner, R.Huang, D.Inglis, F.Johnson, C.Kass, J.Kirk, G.Klostermann, A.Knopman, A.Koplin, A.Krefetz, D.Kressig, R.Lai, R.Lefebvre, G.Leger, G.Leibowitz, M.Levey, A.Leyhe, T.Losk, S.Lyons, K.Martin, J.Massman, P.McWilliam, C.Micallef, S.Middleton, L.Miller, H.Mintzer, J.Mitchell, R.Mofsen, R.Monsch, A.Moore, P.Munic-Miller, D.Nash, M.Neugroschl, J.Newson, M.Noad, R.Olivera, E.Olley, A.Omidvar, O.Parra, M.Pearson, S.Perneczky, R.Peters, O.Potter, G.Price, G.Raymont, V.Rice, L.Ritchie, C.Ritter, A.Robinson, J.Robinson, S.Ross, J.Rujescu, D.Sabbagh, M.Sabet, A.Samson, L.Sass, J.Saxena, M.Schaerf, F.Schlegel, E.Shah, R.Shingleton, R.Sohrabi, H.Stephenson, R.Stratmann, L.Tariot, P.Thein, S.Till, H.Voight, N.Votolato, R.Wallace, L.Watson, D.White, A.Woodward, M.Zamrini, E.Zimmerman, C.
Source
In: The Lancet Neurology. (The Lancet Neurology, July 2021, 20(7):537-547)
Subject
Language
English
ISSN
14744465
14744422